Log in

NYSE:RMD - ResMed Stock Price, Forecast & News

$141.95
-4.57 (-3.12 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$136.00
Now: $141.95
$145.99
50-Day Range
$114.34
MA: $159.57
$176.62
52-Week Range
$96.81
Now: $141.95
$177.99
Volume884,981 shs
Average Volume1.24 million shs
Market Capitalization$20.53 billion
P/E Ratio45.21
Dividend Yield1.06%
Beta0.45
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Read More
ResMed logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP76115210
Phone858-836-5000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.61 billion
Cash Flow$4.57 per share
Book Value$14.42 per share

Profitability

Net Income$404.59 million

Miscellaneous

Employees7,240
Market Cap$20.53 billion
Next Earnings Date5/7/2020 (Estimated)
OptionableOptionable

Receive RMD News and Ratings via Email

Sign-up to receive the latest news and ratings for RMD and its competitors with MarketBeat's FREE daily newsletter.


ResMed (NYSE:RMD) Frequently Asked Questions

How has ResMed's stock been impacted by COVID-19 (Coronavirus)?

ResMed's stock was trading at $153.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RMD shares have decreased by 7.6% and is now trading at $141.95. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of ResMed?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ResMed in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for ResMed.

When is ResMed's next earnings date?

ResMed is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for ResMed.

How were ResMed's earnings last quarter?

ResMed Inc. (NYSE:RMD) released its earnings results on Thursday, January, 30th. The medical equipment provider reported $1.21 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.01 by $0.20. The medical equipment provider earned $736.20 million during the quarter, compared to the consensus estimate of $723.08 million. ResMed had a net margin of 16.34% and a return on equity of 27.25%. ResMed's quarterly revenue was up 13.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.00 EPS. View ResMed's earnings history.

How often does ResMed pay dividends? What is the dividend yield for ResMed?

ResMed announced a quarterly dividend on Friday, January 31st. Investors of record on Thursday, February 13th will be paid a dividend of $0.39 per share on Thursday, March 19th. This represents a $1.56 annualized dividend and a yield of 1.10%. The ex-dividend date of this dividend is Wednesday, February 12th. View ResMed's dividend history.

What price target have analysts set for RMD?

10 brokers have issued 12-month price targets for ResMed's stock. Their forecasts range from $95.00 to $174.00. On average, they anticipate ResMed's stock price to reach $144.67 in the next year. This suggests a possible upside of 1.9% from the stock's current price. View analysts' price targets for ResMed.

Has ResMed been receiving favorable news coverage?

News articles about RMD stock have been trending positive on Saturday, InfoTrie reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ResMed earned a coverage optimism score of 2.4 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutResMed.

Are investors shorting ResMed?

ResMed saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 2,240,000 shares, a decline of 5.5% from the February 13th total of 2,370,000 shares. Based on an average trading volume of 552,700 shares, the days-to-cover ratio is currently 4.1 days. Currently, 1.6% of the company's stock are sold short. View ResMed's Current Options Chain.

Who are some of ResMed's key competitors?

What other stocks do shareholders of ResMed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ResMed investors own include Energy Transfer LP Unit (ET), Starbucks (SBUX), Walt Disney (DIS), Netflix (NFLX), Visa (V), NVIDIA (NVDA), QUALCOMM (QCOM), AT&T (T), Mastercard (MA) and UnitedHealth Group (UNH).

Who are ResMed's key executives?

ResMed's management team includes the following people:
  • Mr. Michael J. Farrell BE, SM, MBA, CEO & Director (Age 47)
  • Mr. Robert A. Douglas, Pres & COO (Age 59)
  • Mr. Brett A. Sandercock, Chief Financial Officer (Age 52)
  • Mr. David B. Pendarvis, Chief Admin. Officer, Global Gen. Counsel & Sec. (Age 60)
  • Mr. James Hollingshead, Pres of Sleep Bus. (Age 56)

What is ResMed's stock symbol?

ResMed trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMD."

Who are ResMed's major shareholders?

ResMed's stock is owned by many different retail and institutional investors. Top institutional shareholders include WCM Investment Management LLC (5.39%), State Street Corp (4.45%), FMR LLC (4.15%), Capital World Investors (3.99%), Baillie Gifford & Co. (3.15%) and Geode Capital Management LLC (1.68%). Company insiders that own ResMed stock include Brett Sandercock, David Pendarvis, Gary W Pace, James Hollingshead, John P Wareham, Michael J Farrell, Rajwant Sodhi, Richard Mchale, Richard Sulpizio, Robert Andrew Douglas and Ronald R Taylor. View institutional ownership trends for ResMed.

Which institutional investors are selling ResMed stock?

RMD stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Westpac Banking Corp, Schroder Investment Management Group, AQR Capital Management LLC, FMR LLC, Skandinaviska Enskilda Banken AB publ, Bank of America Corp DE, and Amundi Pioneer Asset Management Inc.. Company insiders that have sold ResMed company stock in the last year include Brett Sandercock, David Pendarvis, James Hollingshead, John P Wareham, Michael J Farrell, Rajwant Sodhi, Richard Mchale, Robert Andrew Douglas, and Ronald R Taylor. View insider buying and selling activity for ResMed.

Which institutional investors are buying ResMed stock?

RMD stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Janus Henderson Group PLC, Geode Capital Management LLC, First Trust Advisors LP, WCM Investment Management LLC, Renaissance Technologies LLC, Credit Suisse AG, and Franklin Resources Inc.. View insider buying and selling activity for ResMed.

How do I buy shares of ResMed?

Shares of RMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ResMed's stock price today?

One share of RMD stock can currently be purchased for approximately $141.95.

How big of a company is ResMed?

ResMed has a market capitalization of $20.53 billion and generates $2.61 billion in revenue each year. The medical equipment provider earns $404.59 million in net income (profit) each year or $3.64 on an earnings per share basis. ResMed employs 7,240 workers across the globe. View additional information about ResMed.

What is ResMed's official website?

The official website for ResMed is http://www.resmed.com/.

How can I contact ResMed?

ResMed's mailing address is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-836-5000 or via email at [email protected]


MarketBeat Community Rating for ResMed (NYSE RMD)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  351 (Vote Outperform)
Underperform Votes:  629 (Vote Underperform)
Total Votes:  980
MarketBeat's community ratings are surveys of what our community members think about ResMed and other stocks. Vote "Outperform" if you believe RMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel